Affymetrix, OGT Settle Infringement Dispute; Affy to Post $19M Charge | GenomeWeb

NEW YORK, March 26 - Affymetrix and Oxford Gene Technology said Monday they had settled a multinational patent infringement dispute, allowing both companies to proceed in licensing and developing their microarray technology.

The companies, which have been entrenched in a legal battle since 1999, would not disclose the terms of the settlement, but Affymetrix said that it would incure a $19 million charge as well as other possible legal fees.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: mutations linked to nasopharyngeal carcinoma, salivary proteins common among oral squamous cell carcinoma patients, and more.

At Wired, a science journalist discusses her decision not to undergo BRCA testing.

The Japan Times says regulations are needed to oversee human genome-editing research.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.